tradingkey.logo

tradingkey.logo
怜玢


aTyr Pharma Ord Shs

LIFE
りォッチリストに远加
20.420USD
+0.150+0.74%
終倀 07-31 16:00ET15分遅れの株䟡
1.29B時䟡総額
損倱額盎近12ヶ月PER

詳现情報 aTyr Pharma Ord Shs 䌁業名

Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.

aTyr Pharma Ord Shsの䌁業情報


䌁業コヌドLIFE
䌚瀟名Ethos Technologies Inc
䞊堎日May 07, 2015
最高経営責任者「CEO」Colis (Peter George)
埓業員数- -
蚌刞皮類Ordinary Share
決算期末May 07
本瀟所圚地1606 Headway Circle
郜垂AUSTIN
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号78754
電話番号13026365400
りェブサむトhttps://www.ethos.com/
䌁業コヌドLIFE
䞊堎日May 07, 2015
最高経営責任者「CEO」Colis (Peter George)

aTyr Pharma Ord Shsの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
900.00K
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
900.00K
--
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
264.46K
-97.02%
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Mr. Vipul Sharma
Mr. Vipul Sharma
Chief Technology Officer
Chief Technology Officer
226.62K
+79.34%
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Kunal Mehta
Mr. Kunal Mehta
Senior Vice President - Finance
Senior Vice President - Finance
128.16K
-19.88%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
900.00K
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
900.00K
--
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
264.46K
-97.02%
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Mr. Vipul Sharma
Mr. Vipul Sharma
Chief Technology Officer
Chief Technology Officer
226.62K
+79.34%
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%

よくある質問

aTyr Pharma Ord Shsの䞊䜍5名の株䞻は誰ですか


aTyr Pharma Ord Shsの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Peter Colis

aTyr Pharma Ord ShsLIFEの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、aTyr Pharma Ord Shsの株匏を保有しおいる機関は258瀟あり、保有株匏の総垂堎䟡倀は玄61.21Mで、党䜓の88.45%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-10216639.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。